Furthermore, EVs purified from highly EphA2-expressing bladder cancer cells significantly increased the invasiveness of U-BLC1 bladder cancer cells as assessed by Matrigel invasion assay, whereas the knockout of EphA2 inhibited this invasion-promoting effect. The gene discussed is EPHA2; the disease is urinary bladder cancer.